YOUR BUSINESS AUTHORITY
Springfield, MO
YOUR BUSINESS AUTHORITY
Springfield, MO
French pharmaceutical company Sanofi SA signed on to purchase United Kingdom-based Kymab for $1.1 billion.
The acquisition of the biopharmaceutical company also includes payments of up to $350 million upon the achievement of certain milestones.
Kymab focuses on developing fully human monoclonal antibodies.
Read more from MarketWatch.
Guest columnist Donnie Brawner says many entrepreneurs stray from their original business ventures, which is often a recipe for success.